Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) (TSE:NTB) was the recipient of a large decrease in short interest in the month of September. As of September 29th, there was short interest totalling 319,005 shares, a decrease of 81.2% from the September 15th total of 1,695,614 shares. Currently, 0.5% of the company’s stock are sold short. Based on an average daily volume of 125,890 shares, the short-interest ratio is presently 2.5 days.

Shares of Neptune Technologies & Bioresources (NEPT) opened at 0.8425 on Tuesday. The stock has a 50 day moving average of $0.89 and a 200 day moving average of $0.93. The stock has a market cap of $66.25 million, a PE ratio of 12.5746 and a beta of 0.88. Neptune Technologies & Bioresources has a 12 month low of $0.70 and a 12 month high of $1.36.

An institutional investor recently raised its position in Neptune Technologies & Bioresources stock. Alpine Global Management LLC lifted its holdings in Neptune Technologies & Bioresources Inc (NASDAQ:NEPT) (TSE:NTB) by 87.8% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 278,101 shares of the biotechnology company’s stock after purchasing an additional 130,000 shares during the period. Alpine Global Management LLC owned approximately 0.35% of Neptune Technologies & Bioresources worth $234,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 11.99% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Short Interest in Neptune Technologies & Bioresources Inc (NEPT) Declines By 81.2%” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at

Neptune Technologies & Bioresources Company Profile

Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.

Receive News & Stock Ratings for Neptune Technologies & Bioresources Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioresources Inc and related stocks with our FREE daily email newsletter.